According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Angiotensin II Receptor Blockers Market

Angiotensin II receptor blockers help relax your veins and arteries to lower your blood pressure and make it easier for your heart to pump blood.

The global Angiotensin II Receptor Blockers market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Angiotensin II Receptor Blockers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Angiotensin II Receptor Blockers.

Report Scope

The Angiotensin II Receptor Blockers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Angiotensin II Receptor Blockers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Angiotensin II Receptor Blockers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Angiotensin II Receptor Blockers Market Report

Report Metric	Details
Report Name	Angiotensin II Receptor Blockers Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Azilsartan Candesartan Eprosartan Irbesartan Losartan Olmesartan Telmisartan Valsartan
Segment by Application	Chronic Kidney Diseases Heart Failure Kidney Failure in Diabetes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck & Co., AstraZeneca, Novartis, Teva, Bayer, GlaxoSmithKline, Sun Pharmaceutical, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Angiotensin II Receptor Blockers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Angiotensin II Receptor Blockers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Angiotensin II Receptor Blockers Market report?

Ans: The main players in the Angiotensin II Receptor Blockers Market are Merck & Co., AstraZeneca, Novartis, Teva, Bayer, GlaxoSmithKline, Sun Pharmaceutical, Mylan

What are the Application segmentation covered in the Angiotensin II Receptor Blockers Market report?

Ans: The Applications covered in the Angiotensin II Receptor Blockers Market report are Chronic Kidney Diseases, Heart Failure, Kidney Failure in Diabetes

What are the Type segmentation covered in the Angiotensin II Receptor Blockers Market report?

Ans: The Types covered in the Angiotensin II Receptor Blockers Market report are Azilsartan, Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Valsartan

1 Angiotensin II Receptor Blockers Market Overview

1.1 Product Overview and Scope of Angiotensin II Receptor Blockers

1.2 Angiotensin II Receptor Blockers Segment by Type

1.2.1 Global Angiotensin II Receptor Blockers Market Value Comparison by Type (2024-2030)

1.2.2 Azilsartan

1.2.3 Candesartan

1.2.4 Eprosartan

1.2.5 Irbesartan

1.2.6 Losartan

1.2.7 Olmesartan

1.2.8 Telmisartan

1.2.9 Valsartan

1.3 Angiotensin II Receptor Blockers Segment by Application

1.3.1 Global Angiotensin II Receptor Blockers Market Value by Application: (2024-2030)

1.3.2 Chronic Kidney Diseases

1.3.3 Heart Failure

1.3.4 Kidney Failure in Diabetes

1.4 Global Angiotensin II Receptor Blockers Market Size Estimates and Forecasts

1.4.1 Global Angiotensin II Receptor Blockers Revenue 2019-2030

1.4.2 Global Angiotensin II Receptor Blockers Sales 2019-2030

1.4.3 Global Angiotensin II Receptor Blockers Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Angiotensin II Receptor Blockers Market Competition by Manufacturers

2.1 Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturers (2019-2024)

2.2 Global Angiotensin II Receptor Blockers Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Angiotensin II Receptor Blockers Average Price by Manufacturers (2019-2024)

2.4 Global Angiotensin II Receptor Blockers Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Angiotensin II Receptor Blockers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Angiotensin II Receptor Blockers, Product Type & Application

2.7 Angiotensin II Receptor Blockers Market Competitive Situation and Trends

2.7.1 Angiotensin II Receptor Blockers Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Angiotensin II Receptor Blockers Players Market Share by Revenue

2.7.3 Global Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Angiotensin II Receptor Blockers Retrospective Market Scenario by Region

3.1 Global Angiotensin II Receptor Blockers Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Angiotensin II Receptor Blockers Global Angiotensin II Receptor Blockers Sales by Region: 2019-2030

3.2.1 Global Angiotensin II Receptor Blockers Sales by Region: 2019-2024

3.2.2 Global Angiotensin II Receptor Blockers Sales by Region: 2025-2030

3.3 Global Angiotensin II Receptor Blockers Global Angiotensin II Receptor Blockers Revenue by Region: 2019-2030

3.3.1 Global Angiotensin II Receptor Blockers Revenue by Region: 2019-2024

3.3.2 Global Angiotensin II Receptor Blockers Revenue by Region: 2025-2030

3.4 North America Angiotensin II Receptor Blockers Market Facts & Figures by Country

3.4.1 North America Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Angiotensin II Receptor Blockers Sales by Country (2019-2030)

3.4.3 North America Angiotensin II Receptor Blockers Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Angiotensin II Receptor Blockers Market Facts & Figures by Country

3.5.1 Europe Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Angiotensin II Receptor Blockers Sales by Country (2019-2030)

3.5.3 Europe Angiotensin II Receptor Blockers Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Angiotensin II Receptor Blockers Market Facts & Figures by Country

3.6.1 Asia Pacific Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Angiotensin II Receptor Blockers Sales by Country (2019-2030)

3.6.3 Asia Pacific Angiotensin II Receptor Blockers Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Angiotensin II Receptor Blockers Market Facts & Figures by Country

3.7.1 Latin America Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Angiotensin II Receptor Blockers Sales by Country (2019-2030)

3.7.3 Latin America Angiotensin II Receptor Blockers Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Angiotensin II Receptor Blockers Market Facts & Figures by Country

3.8.1 Middle East and Africa Angiotensin II Receptor Blockers Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Angiotensin II Receptor Blockers Sales by Country (2019-2030)

3.8.3 Middle East and Africa Angiotensin II Receptor Blockers Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Angiotensin II Receptor Blockers Sales by Type (2019-2030)

4.1.1 Global Angiotensin II Receptor Blockers Sales by Type (2019-2024)

4.1.2 Global Angiotensin II Receptor Blockers Sales by Type (2025-2030)

4.1.3 Global Angiotensin II Receptor Blockers Sales Market Share by Type (2019-2030)

4.2 Global Angiotensin II Receptor Blockers Revenue by Type (2019-2030)

4.2.1 Global Angiotensin II Receptor Blockers Revenue by Type (2019-2024)

4.2.2 Global Angiotensin II Receptor Blockers Revenue by Type (2025-2030)

4.2.3 Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2019-2030)

4.3 Global Angiotensin II Receptor Blockers Price by Type (2019-2030)

5 Segment by Application

5.1 Global Angiotensin II Receptor Blockers Sales by Application (2019-2030)

5.1.1 Global Angiotensin II Receptor Blockers Sales by Application (2019-2024)

5.1.2 Global Angiotensin II Receptor Blockers Sales by Application (2025-2030)

5.1.3 Global Angiotensin II Receptor Blockers Sales Market Share by Application (2019-2030)

5.2 Global Angiotensin II Receptor Blockers Revenue by Application (2019-2030)

5.2.1 Global Angiotensin II Receptor Blockers Revenue by Application (2019-2024)

5.2.2 Global Angiotensin II Receptor Blockers Revenue by Application (2025-2030)

5.2.3 Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2019-2030)

5.3 Global Angiotensin II Receptor Blockers Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck & Co.

6.1.1 Merck & Co. Corporation Information

6.1.2 Merck & Co. Description and Business Overview

6.1.3 Merck & Co. Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck & Co. Angiotensin II Receptor Blockers Product Portfolio

6.1.5 Merck & Co. Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.2.4 AstraZeneca Angiotensin II Receptor Blockers Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Novartis Angiotensin II Receptor Blockers Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Teva

6.4.1 Teva Corporation Information

6.4.2 Teva Description and Business Overview

6.4.3 Teva Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Teva Angiotensin II Receptor Blockers Product Portfolio

6.4.5 Teva Recent Developments/Updates

6.5 Bayer

6.5.1 Bayer Corporation Information

6.5.2 Bayer Description and Business Overview

6.5.3 Bayer Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Bayer Angiotensin II Receptor Blockers Product Portfolio

6.5.5 Bayer Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Corporation Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.6.4 GlaxoSmithKline Angiotensin II Receptor Blockers Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Sun Pharmaceutical

6.6.1 Sun Pharmaceutical Corporation Information

6.6.2 Sun Pharmaceutical Description and Business Overview

6.6.3 Sun Pharmaceutical Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Sun Pharmaceutical Angiotensin II Receptor Blockers Product Portfolio

6.7.5 Sun Pharmaceutical Recent Developments/Updates

6.8 Mylan

6.8.1 Mylan Corporation Information

6.8.2 Mylan Description and Business Overview

6.8.3 Mylan Angiotensin II Receptor Blockers Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Mylan Angiotensin II Receptor Blockers Product Portfolio

6.8.5 Mylan Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Angiotensin II Receptor Blockers Industry Chain Analysis

7.2 Angiotensin II Receptor Blockers Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Angiotensin II Receptor Blockers Production Mode & Process

7.4 Angiotensin II Receptor Blockers Sales and Marketing

7.4.1 Angiotensin II Receptor Blockers Sales Channels

7.4.2 Angiotensin II Receptor Blockers Distributors

7.5 Angiotensin II Receptor Blockers Customers

8 Angiotensin II Receptor Blockers Market Dynamics

8.1 Angiotensin II Receptor Blockers Industry Trends

8.2 Angiotensin II Receptor Blockers Market Drivers

8.3 Angiotensin II Receptor Blockers Market Challenges

8.4 Angiotensin II Receptor Blockers Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Angiotensin II Receptor Blockers Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Angiotensin II Receptor Blockers Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Angiotensin II Receptor Blockers Market Competitive Situation by Manufacturers in 2023

Table 4. Global Angiotensin II Receptor Blockers Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Angiotensin II Receptor Blockers Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Angiotensin II Receptor Blockers Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Angiotensin II Receptor Blockers Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Angiotensin II Receptor Blockers, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Angiotensin II Receptor Blockers, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Angiotensin II Receptor Blockers, Product Type & Application

Table 12. Global Key Manufacturers of Angiotensin II Receptor Blockers, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Angiotensin II Receptor Blockers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin II Receptor Blockers as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Angiotensin II Receptor Blockers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Angiotensin II Receptor Blockers Sales by Region (2019-2024) & (K Units)

Table 18. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2019-2024)

Table 19. Global Angiotensin II Receptor Blockers Sales by Region (2025-2030) & (K Units)

Table 20. Global Angiotensin II Receptor Blockers Sales Market Share by Region (2025-2030)

Table 21. Global Angiotensin II Receptor Blockers Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2019-2024)

Table 23. Global Angiotensin II Receptor Blockers Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Angiotensin II Receptor Blockers Revenue Market Share by Region (2025-2030)

Table 25. North America Angiotensin II Receptor Blockers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Angiotensin II Receptor Blockers Sales by Country (2019-2024) & (K Units)

Table 27. North America Angiotensin II Receptor Blockers Sales by Country (2025-2030) & (K Units)

Table 28. North America Angiotensin II Receptor Blockers Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Angiotensin II Receptor Blockers Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Angiotensin II Receptor Blockers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Angiotensin II Receptor Blockers Sales by Country (2019-2024) & (K Units)

Table 32. Europe Angiotensin II Receptor Blockers Sales by Country (2025-2030) & (K Units)

Table 33. Europe Angiotensin II Receptor Blockers Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Angiotensin II Receptor Blockers Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Angiotensin II Receptor Blockers Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Angiotensin II Receptor Blockers Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Angiotensin II Receptor Blockers Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Angiotensin II Receptor Blockers Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Angiotensin II Receptor Blockers Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Angiotensin II Receptor Blockers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Angiotensin II Receptor Blockers Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Angiotensin II Receptor Blockers Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Angiotensin II Receptor Blockers Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Angiotensin II Receptor Blockers Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Angiotensin II Receptor Blockers Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Angiotensin II Receptor Blockers Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Angiotensin II Receptor Blockers Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Angiotensin II Receptor Blockers Sales (K Units) by Type (2019-2024)

Table 51. Global Angiotensin II Receptor Blockers Sales (K Units) by Type (2025-2030)

Table 52. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2019-2024)

Table 53. Global Angiotensin II Receptor Blockers Sales Market Share by Type (2025-2030)

Table 54. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2019-2024)

Table 57. Global Angiotensin II Receptor Blockers Revenue Market Share by Type (2025-2030)

Table 58. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2019-2024)

Table 59. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2025-2030)

Table 60. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2019-2024)

Table 61. Global Angiotensin II Receptor Blockers Sales (K Units) by Application (2025-2030)

Table 62. Global Angiotensin II Receptor Blockers Sales Market Share by Application (2019-2024)

Table 63. Global Angiotensin II Receptor Blockers Sales Market Share by Application (2025-2030)

Table 64. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Angiotensin II Receptor Blockers Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2019-2024)

Table 67. Global Angiotensin II Receptor Blockers Revenue Market Share by Application (2025-2030)

Table 68. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2019-2024)

Table 69. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2025-2030)

Table 70. Merck & Co. Corporation Information

Table 71. Merck & Co. Description and Business Overview

Table 72. Merck & Co. Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Merck & Co. Angiotensin II Receptor Blockers Product

Table 74. Merck & Co. Recent Developments/Updates

Table 75. AstraZeneca Corporation Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. AstraZeneca Angiotensin II Receptor Blockers Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Novartis Corporation Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Novartis Angiotensin II Receptor Blockers Product

Table 84. Novartis Recent Developments/Updates

Table 85. Teva Corporation Information

Table 86. Teva Description and Business Overview

Table 87. Teva Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Teva Angiotensin II Receptor Blockers Product

Table 89. Teva Recent Developments/Updates

Table 90. Bayer Corporation Information

Table 91. Bayer Description and Business Overview

Table 92. Bayer Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Bayer Angiotensin II Receptor Blockers Product

Table 94. Bayer Recent Developments/Updates

Table 95. GlaxoSmithKline Corporation Information

Table 96. GlaxoSmithKline Description and Business Overview

Table 97. GlaxoSmithKline Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. GlaxoSmithKline Angiotensin II Receptor Blockers Product

Table 99. GlaxoSmithKline Recent Developments/Updates

Table 100. Sun Pharmaceutical Corporation Information

Table 101. Sun Pharmaceutical Description and Business Overview

Table 102. Sun Pharmaceutical Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Sun Pharmaceutical Angiotensin II Receptor Blockers Product

Table 104. Sun Pharmaceutical Recent Developments/Updates

Table 105. Mylan Corporation Information

Table 106. Mylan Description and Business Overview

Table 107. Mylan Angiotensin II Receptor Blockers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Mylan Angiotensin II Receptor Blockers Product

Table 109. Mylan Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Angiotensin II Receptor Blockers Distributors List

Table 113. Angiotensin II Receptor Blockers Customers List

Table 114. Angiotensin II Receptor Blockers Market Trends

Table 115. Angiotensin II Receptor Blockers Market Drivers

Table 116. Angiotensin II Receptor Blockers Market Challenges

Table 117. Angiotensin II Receptor Blockers Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Angiotensin II Receptor Blockers

Figure 2. Global Angiotensin II Receptor Blockers Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Angiotensin II Receptor Blockers Market Share by Type in 2023 & 2030

Figure 4. Azilsartan Product Picture

Figure 5. Candesartan Product Picture

Figure 6. Eprosartan Product Picture

Figure 7. Irbesartan Product Picture

Figure 8. Losartan Product Picture

Figure 9. Olmesartan Product Picture

Figure 10. Telmisartan Product Picture

Figure 11. Valsartan Product Picture

Figure 12. Global Angiotensin II Receptor Blockers Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Angiotensin II Receptor Blockers Market Share by Application in 2023 & 2030

Figure 14. Chronic Kidney Diseases

Figure 15. Heart Failure

Figure 16. Kidney Failure in Diabetes

Figure 17. Global Angiotensin II Receptor Blockers Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Angiotensin II Receptor Blockers Market Size (2019-2030) & (US$ Million)

Figure 19. Global Angiotensin II Receptor Blockers Sales (2019-2030) & (K Units)

Figure 20. Global Angiotensin II Receptor Blockers Average Price (USD/Unit) & (2019-2030)

Figure 21. Angiotensin II Receptor Blockers Report Years Considered

Figure 22. Angiotensin II Receptor Blockers Sales Share by Manufacturers in 2023

Figure 23. Global Angiotensin II Receptor Blockers Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest Angiotensin II Receptor Blockers Players: Market Share by Revenue in 2023

Figure 25. Angiotensin II Receptor Blockers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global Angiotensin II Receptor Blockers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America Angiotensin II Receptor Blockers Sales Market Share by Country (2019-2030)

Figure 28. North America Angiotensin II Receptor Blockers Revenue Market Share by Country (2019-2030)

Figure 29. U.S. Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe Angiotensin II Receptor Blockers Sales Market Share by Country (2019-2030)

Figure 32. Europe Angiotensin II Receptor Blockers Revenue Market Share by Country (2019-2030)

Figure 33. Germany Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Angiotensin II Receptor Blockers Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific Angiotensin II Receptor Blockers Revenue Market Share by Region (2019-2030)

Figure 40. China Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Taiwan Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Indonesia Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Thailand Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Malaysia Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Philippines Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Latin America Angiotensin II Receptor Blockers Sales Market Share by Country (2019-2030)

Figure 51. Latin America Angiotensin II Receptor Blockers Revenue Market Share by Country (2019-2030)

Figure 52. Mexico Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Argentina Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Middle East & Africa Angiotensin II Receptor Blockers Sales Market Share by Country (2019-2030)

Figure 56. Middle East & Africa Angiotensin II Receptor Blockers Revenue Market Share by Country (2019-2030)

Figure 57. Turkey Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. U.A.E Angiotensin II Receptor Blockers Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. Global Sales Market Share of Angiotensin II Receptor Blockers by Type (2019-2030)

Figure 61. Global Revenue Market Share of Angiotensin II Receptor Blockers by Type (2019-2030)

Figure 62. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Type (2019-2030)

Figure 63. Global Sales Market Share of Angiotensin II Receptor Blockers by Application (2019-2030)

Figure 64. Global Revenue Market Share of Angiotensin II Receptor Blockers by Application (2019-2030)

Figure 65. Global Angiotensin II Receptor Blockers Price (USD/Unit) by Application (2019-2030)

Figure 66. Angiotensin II Receptor Blockers Value Chain

Figure 67. Angiotensin II Receptor Blockers Production Process

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Distributors Profiles

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions